Icon
Image
PPH
Postpartum Hemorrhage
Icon White
Image
Post Partum Haemorrage
Joint statement of recommendation for the use of tranexamic acid for the treatment of postpartum haemorrhage

Postpartum haemorrhage (PPH) is a devastating but preventable condition that affects mothers and their children around the world. PPH occurs when a mother has serious bleeding after giving birth. When not treated quickly, it can be fatal. Most deaths from PPH could be avoided through active management of the third stage of laour, and prompt and effective application of the first response bundle (use of uterotonics, uterine massage, fluid replacement and tranexamic acid [TXA]).

We are deeply saddened to receive news of the death of Winnie Naisianoi Shena-Mureithi, CEO of the Kenya Obstetrical and Gynaecological Society (KOGS).

Winnie was a wonderful and passionate leader, dedicated to serving women and supporting life through her work as a midwife and with KOGS. She successfully led teams in Kenya in their implementation of FIGO’s Advocating Safe Abortion Project (ASAP) and as Deputy Country Coordinator for the Post-partum Intrauterine Device (PPIUD) initiative. 

Winnie Naisianoi Shena-Mureithi

The POPPHI Project is part of the United States Agency for International Development’s (USAID’s) broader Special Initiative to reduce postpartum haemorrhage, the single most important cause of maternal deaths worldwide, through expanded use of Active Management of the Third Stage of Labour (AMTSL). AMTSL is an intervention that reduces the incidence of postpartum haemorrhage by up to 60 percent.

Report on the POPPHI / FIGO trip to Mali and Benin
Rome, October 11th, 2012 – The Millennium Development Goal 5, targeting the “improvement of maternal health”, is one of the eight set by the United Nations in 1990 - to achieve by 2015 -  that has made some progress, albeit slow. In 2010, the UN Secretary-General launched the ‘Global Strategy for Women’s and Children’s Health’ to mobilise commitments by governments and civil society organisations to accelerate progress towards it.
FIGO CONGRESS NEWS: How to make a difference in maternal and newborn health outcomes
On the occasion of International Women’s Day (8 March), the International Confederation of Midwives (ICM) and the International Federation of Gynecology and Obstetrics (FIGO) are pleased to launch a joint statement on the use of misoprostol for the treatment of postpartum haemorrhage.
ICM and FIGO launch joint statement on the use of misoprostol for the treatment of postpartum haemorrhage